Filippetti, M.; Tamburin, S.; Di Censo, R.; Aldegheri, R.; Mantovani, E.; Spina, S.; Battaglia, M.; Baricich, A.; Santamato, A.; Smania, N.;
et al. Do Diagnostic Nerve Blocks Affect the Starting Dose of Botulinum Neurotoxin Type A for Spasticity? A Case-Control Study. Toxins 2024, 16, 388.
https://doi.org/10.3390/toxins16090388
AMA Style
Filippetti M, Tamburin S, Di Censo R, Aldegheri R, Mantovani E, Spina S, Battaglia M, Baricich A, Santamato A, Smania N,
et al. Do Diagnostic Nerve Blocks Affect the Starting Dose of Botulinum Neurotoxin Type A for Spasticity? A Case-Control Study. Toxins. 2024; 16(9):388.
https://doi.org/10.3390/toxins16090388
Chicago/Turabian Style
Filippetti, Mirko, Stefano Tamburin, Rita Di Censo, Roberto Aldegheri, Elisa Mantovani, Stefania Spina, Marco Battaglia, Alessio Baricich, Andrea Santamato, Nicola Smania,
and et al. 2024. "Do Diagnostic Nerve Blocks Affect the Starting Dose of Botulinum Neurotoxin Type A for Spasticity? A Case-Control Study" Toxins 16, no. 9: 388.
https://doi.org/10.3390/toxins16090388
APA Style
Filippetti, M., Tamburin, S., Di Censo, R., Aldegheri, R., Mantovani, E., Spina, S., Battaglia, M., Baricich, A., Santamato, A., Smania, N., & Picelli, A.
(2024). Do Diagnostic Nerve Blocks Affect the Starting Dose of Botulinum Neurotoxin Type A for Spasticity? A Case-Control Study. Toxins, 16(9), 388.
https://doi.org/10.3390/toxins16090388